# A Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Advanced Colorectal Cancer

> **NCT02399943** · PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 14 (actual)

## Conditions studied

- Colorectal Cancer
- KRAS Wildtype
- NRAS Wildtype
- BRAF Wildtype

## Interventions

- **DRUG:** Trametinib
- **DRUG:** Panitumumab

## Key facts

- **NCT ID:** NCT02399943
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2019-04
- **Final completion:** 2022-03-31
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2022-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02399943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02399943, "A Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Advanced Colorectal Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02399943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*